BMC Public Health | |
Protocol for a randomised pragmatic policy trial of nicotine products for quitting or long-term substitution in smokers | |
Study Protocol | |
Doug Fraser1  Coral Gartner2  Ron Borland3  | |
[1] School of Public Health, The University of Queensland, Brisbane, Australia;School of Public Health, The University of Queensland, Brisbane, Australia;The University of Queensland Centre for Clinical Research, Brisbane, Australia;The Cancer Council Victoria, Melbourne, Australia;The University of Queensland Centre for Clinical Research, Brisbane, Australia; | |
关键词: E-cigarettes; Nicotine; Pragmatic trial; Randomized controlled trial; Harm-reduction; Smoking; | |
DOI : 10.1186/s12889-015-2366-1 | |
received in 2015-09-18, accepted in 2015-09-29, 发布年份 2015 | |
来源: Springer | |
【 摘 要 】
BackgroundSmoking is Australia’s leading preventable cause of premature mortality and a major contributor to the national disease burden. If quit rates do not dramatically improve, then smoking will continue to be a major public health issue for decades to come. Harm-reduction approaches using novel nicotine products like e-cigarettes as long term replacements for smoking have the potential to improve quit rates. However, little research has assessed such approaches.Methods/DesignDesign: Three-arm parallel-group pragmatic randomised controlled trial.Participants: People living in Australia who are at least 18 years old, smoke five or more cigarettes per day and are willing to try a sample of nicotine products.Intervention: Participants are randomised to receive standard quit advice and medicinal nicotine (Condition A); quit or substitute advice and medicinal nicotine (Condition B); or quit or substitute advice and medicinal nicotine and e-cigarettes (Condition C). Participants choose which (if any) nicotine products to receive to try in a free sample pack followed by a two to three week free supply of their favourite product(s) and the option to purchase more at a discounted price. Follow-up surveys will assess nicotine product use and smoking.Primary outcome: Continuous abstinence for at least 6 months.Target sample size: 1600 people (Condition A: 340; Condition B: 630; Condition C: 630) provides at least 80 % power at p = 0.05 to detect a 5 % difference in abstinence rates between each condition.DiscussionThis trial will provide data on tobacco harm-reduction approaches and in particular the use of e-cigarettes as a replacement for smoking.Trial registrationAustralian and New Zealand Clinical Trials Registry: ACTRN12612001210864. Date of registration: 15/11/2012.
【 授权许可】
CC BY
© Fraser et al. 2015
【 预 览 】
Files | Size | Format | View |
---|---|---|---|
RO202311096735383ZK.pdf | 769KB | download |
【 参考文献 】
- [1]
- [2]
- [3]
- [4]
- [5]
- [6]
- [7]
- [8]
- [9]
- [10]
- [11]
- [12]
- [13]
- [14]
- [15]
- [16]
- [17]
- [18]
- [19]
- [20]
- [21]
- [22]
- [23]
- [24]
- [25]
- [26]